Association of the Lewis genotype with cardiovascular risk factors and subclinical carotid atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) study

Journal of Internal Medicine

Volumn 255, Issue 1, 2004, Pages 40-51

  Cakir, B ^a   Heiss, G ^b,g   Pankow, J S ^c   Salomaa, V ^d   Sharrett, A R ^e   Couper, D ^b   Weston, B W ^f  

^a HACETTEPE UNIVERSITY   (Turkey)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g Bank of America Corp   (United States)

Author keywords

(1,3 1,4) L fucosyltransferase; Carotid atherosclerosis; FUT3 gene; Lewis gene

Indexed keywords

BLOOD CLOTTING FACTOR 8C; VON WILLEBRAND FACTOR;

ADULT; AFRICAN AMERICAN; AGE DETERMINATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD GROUP LEWIS SYSTEM; CARDIOVASCULAR RISK; CAROTID ARTERY; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; TUNICA MEDIA; ULTRASOUND;

BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FACTOR VIII; FEMALE; FUCOSYLTRANSFERASES; GENOTYPE; HETEROZYGOTE; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 1642580752     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01263.x     Document Type: Article

References (33)

1. Hein HO, Sørensen H, Suadicani P, Gyntelberg F. The Lewis blood group - a new genetic marker of ischaemic heart disease. J Int Med 1992; 232: 481-7.
2. Green D, Jarrett O, Ruth KJ, Folsom AR, Liu K. Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med 1995; 125: 334-9.
3. Zhiburt BB, Chepel AI, Serebryanaya NB et al. Antigen system Lewis as a risk marker of ischaemic heart disease. Ter Arkh 1997; 69: 29-31 (in Russian).
4. Chaudhary R, Shukla JS. Association of Lewis blood group with ischaemic heart disease. Indian J Med Res 1999; 109: 103-4.
5. Ellison RC, Zhang Y, Myers RH, Swanson JL, Higgins M, Eckfeldt J. Lewis blood group phenotype as an independent risk factor for coronary heart disease (The NHLBI Family Heart Study). Am J Cardiol 1999; 83: 345-8.
6. Petit JM, Morvan Y, Mansuy-Collignon S et al. Hypertriglyceridemia and Lewis (a-b-) phenotype in non-insulin-dependent diabetic patients. Diabetes Metab 1997; 23: 202-4.
7. Andersen J, Lauritzen E. Blood groups and diabetes mellitus. Diabetes 1960; 9: 20-4.
8. Langman JS, Elwood PC, Foote J, Ryrie DR. ABO and Lewis blood-groups and serum cholesterol. Lancet 1969; 607-9.
9. Clausen JO, Hein HO, Suadicani P, Winther K, Gyntelberg F, Pedersen O. Lewis phenotypes and the insulin resistance syndrome in young healthy white men and women. Am J Hypertens 1995; 8: 1060-66.
10. Petit JM, Morvan Y, Viviani V et al. Insulin resistance syndrome and Lewis phenotype in healthy men and women. Horm Metab Res 1997; 29: 193-5.
11. Salomaa V, Pankow J, Heiss G et al. Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disese in the NHLBI Family Heart Study. J Intern Med 2000; 247: 689-98.
12. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
13. Chambless LE, Zhong MM, Arnett D, Folsom AR, Riley WA, Heiss G. Variability in B-mode ultrasound measurements in the Atherosclerosis Risk in Communities (ARIC) study. Ultrasound Med Biol 1996; 22: 545-54.
14. Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α (1,3/1,4) fucosyltransferase. Genes Dev 1990; 4: 1288-303.
15. Cakir B, Pankow JS, Salomaa V et al. Distribution of Lewis (FUT3) genotype and allele frequencies in a bi-ethnic U.S. population. Ann Hematol 2002; 81: 558-65.
16. Elmgren A. Mollicone R, Costache M et al. Significance of individual pont mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human α(1,3/1,4)-fucosyltransferase, Fut-TIII. J Biol Chem 1997; 272: 21994-2199.
17. Chambless LE, Heiss G, Folsom AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol 1997; 146: 483-94.
18. Riley WA, Barnes RW, Bond MG, Evans G, Chambless LE, Heiss G. High resolution B mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimaging 1991; 1: 168-72.
19. Bond MG, Barnes RW, Riley WA et al. High resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities study (ARIC). J Neuroimaging 1991; 1: 68-72.
20. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoprotein A-I, and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. ArteriosclerThromb 1994; 114: 1098-104.
21. National Heart, Lung, and Blood Instititute. The Atherosclerosis Risk in Communities (ARIC) Study: Operations Manual. No 1: General Description and Study Management, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina, 1987.
22. National Heart, Lung, and Blood Instititute. The Atherosclerosis Risk in Communities (ARIC) Study: Operations Manual, No. 12: Quality Assurance and Quality Control, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina. 1987.
23. SAS Institute Inc. SA/STAT Users' Guide, version 6, 4th edn. vols 1 and 2. Cary, NC: SAS Institute, 1990.
24. Shah BV, Barnwell BG, Bieler GS, for the Research Triangle Institute. SUDAAN Software for the Statistical Analysis of Correlated Data. User's Manual, vols 1 and 2. Research Triangle Park, NC: Research Triangle Institute, 1997.
25. Schneider S, Kueffer JM, Roessli D, Excoffier L. Arlequin ver. 1.1: A Software for Population Genetic Data Analysis. Geneva. Switzerland: Genetics and Biometry Laboratory, University of Geneva. 1997.
26. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia. PA: Lippincott-Raven Publishers, 1998.
27. Swanson JL, McCullough J. Lewis phenotypes [letter]. J Lab Clin Med 1996; 127: 104.
28. Hein HO, Sørensen H, Suadicani P, Gyntelberg F. Alcohol consumption. Lewis phenotypes, and risk of ischaemic heart disease. Lancet 1993; 341: 392-6.
29. Ingles SA, Haile RW, Henderson BE et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997; 6: 93-8.
30. Weston BW, Nair RP, Larsen RD, Lowe JB. Isolation of a novel human α (1,3) fucosyltransferase gene and molecular comparison to the human Lewis blood group α (1,3/1,4) fucosyltransferase gene. Synthenic, homologous, nonallellic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem 1992; 267: 4152-60.
31. x epitopes. J Biol Chem 1992; 267: 24575-84.
32. Nishihara S, Yazawa S, Iwasaki H et al. α(1,3/1,4)fucosyl- transferase (Fuc-T-III) gene is inactivated by a single amino-acid substitution in Lewis histo-blood type negative individuals. Biochem Biophy Res Comm 1993; 196: 624-31.
33. b-active glycolipid in serum of pregnant women. Vox Sang 1981; 40: 27-33.